BLK
46
2
LUV
45
3
NDAQ
46
2
UA
48
6
UAL
73
3
IRM
33
5
DNB
72
4
HOG
29
4
EW
55
5
BAX
38
2
APA
30
5
NRG
32
5
L
54
5
DHI
36
3
ACN
54
2
QRVO
16
-6
DGX
28
4
EOG
28
2
DIS
70
2
KLAC
45
3
BLK
46
2
LUV
45
3
NDAQ
46
2
UA
48
6
UAL
73
3
IRM
33
5
DNB
72
4
HOG
29
4
EW
55
5
BAX
38
2
APA
30
5
NRG
32
5
L
54
5
DHI
36
3
ACN
54
2
QRVO
16
-6
DGX
28
4
EOG
28
2
DIS
70
2
KLAC
45
3
Financhill
Back

Sandoz Group AG Quote, Financials, Valuation and Earnings

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
15

SDZNY
Sandoz Group AG

Last Price:
$41.60
Seasonality Move:
-1.06%

7 Day Trial

ALL ACCESS PASS

$ 7

The AI Energy Miracle

Details Here.

Sandoz Group AG Price Quote

$41.60

Sandoz Group AG Key Stats

Sell
15
Sandoz Group AG (SDZNY) is a Sell
Day range:
$41.01 - $41.80
52-week range:
$27.79 - $46.80
Dividend yield:
1.19%
P/E ratio:
231.11
P/S ratio:
10.95
P/B ratio:
2.14%
Volume:
43.3K
Avg. volume:
49K
1-year change:
32.79%
Market cap:
$17.9B
Revenue:
$10B
EPS:
$1.64

How Much Does Sandoz Group AG Make?

Data Unavailable

Is Sandoz Group AG Growing As A Company?

Data Unavailable

Sandoz Group AG Stock Price Performance

  • Did Sandoz Group AG Stock Go Up Last Month?
    Sandoz Group AG share price went down by -7.54% last month
  • Did SDZNY's Share Price Rise Over The Last Year?
    SDZNY share price rose by 32.79% over the past 1 year

What Is Sandoz Group AG 52-Week High & Low?

Sandoz Group AG Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Sandoz Group AG?

Data Unavailable

Is Sandoz Group AG Cash Flow Positive?

Data Unavailable

Sandoz Group AG Return On Invested Capital

Data Unavailable

Sandoz Group AG Earnings Date & Stock Price

Sandoz Group AG Competitors

  • Who Are Sandoz Group AG's Competitors?
    Below is a list of companies who compete with Sandoz Group AG or are related in some way:
    • AC Immune SA (ACIU)
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • Molecular Partners AG (MOLN)
    • NLS Pharmaceutics Ltd (NLSP)

Sandoz Group AG Dividend Yield

Data Unavailable

Sandoz Group AG Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -70.26% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable